Summary
The specificity of fenfluramine as a pharmacological probe of the serotonin system has been questioned, since animal studies with high dose 1-fenfluramine show increases in striatal levels of the dopamine metabolite homo-vanillic acid. To test the specificity of fenfluramine in humans with clinical doses, we compared plasma homovanillic acid (pHVA) concentration in healthy volunteers after administration of fenfluramine (60 mg) and placebo. There were no significant effects on pHVA, which supports previous findings that at doses used in pharmacological challenge paradigms, the effect of fenfluramine on the dopamine system is insufficient to alter measures of its change.
This is a preview of subscription content, log in via an institution to check access.
References
Appel NM, Mitchell M, Contrera JF, De Souza EB (1990) Effects of high-dose fenfluramine treatment on monoamine uptake sites in rat brain: assessment using quantitative autoradiography. Synapse 6: 33–44
Asnis GM, Eisenberg J, Van Praag HM, Lemus CZ, Harkavy-Friedman JM, Miller AH (1988) The neuroendocrine response to fenfluramine in depressives and normal controls. Biol Psychiatry 24: 117–120
Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, Mohs RC, Davis KL (1989) Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry 46: 587–599
Fri CG, Frits-Axel W, Goran S (1974) Simultaneous quantification of homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid by mass fragmentography. Life Sci 14: 2469–2480
Fuxe K, Farnebo LO, Hamberger B, Ogren SO (1975) On the in vivo and in vitro actions of fenfluramine and its derivatives on central monoamine neurons, especially 5-hydroxytryptamine neurons, and their relation to ther anorectic activity of fenfluramine. Postgrad Med J 51 [Suppl 1]: 35–45
Garratini S, Caccia S, Mennini T, Samamin R, Consolo S, Ladinsky (1979) Biochemical pharmacology of the anorectic drug fenfluramine: a review. Curr Med Res Opin 6: 15
Hollander E, DeCaria C, Nitescu A, Gully R, Suckow RF, Cooper TB, Gorman JM, Klein DF, Liebowitz MR (1992) Serotonergic function in obsessive-compulsive disorder: comparison of behavioral and neuroendocrine responses to oral m-CPP and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry 49: 21–28
Invernizzi R, Berettera C, Garattini S, Samanin R (1986) D- and L-isomers of fenfluramine differ markedly in their interaction with brain serotonin and catecholamines in the rat. Eur J Pharmacol 120: 9–15
McBride PA, Anderson GM, Hertzig ME, Sweeney JA, Kream J, Cohen DJ, Mann JJ (1989) Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study. Arch Gen Psychiatry 46: 213–221
Meyerendorff E, Jain A, Traksman-Bendz L, Stanley B, Stanley M (1986) The effects of fenfluramine on suicidal behavior. Psychopharmacol Bull 22: 155–159
Raleigh MJ, Brammer GL, Ritvo ER, Geller E, McGuire MT, Yuwiler A (1986) Effects of chronic fenfluramine on blood serotonin, cerebrospinal fluid metabolites, and behavior in monkeys. Psychopharmacology 990: 503–508
Targum SD, Marshall LE (1989) Fenfluramine provocation of anxiety in patients with panic disorder. Psychiatry Res 28: 295–306
Trulson ME, Jacobs BL (1976) Behavioral evidence for the rapid release of CNS serotonin by PCA and fenfluramine. Eur J Pharmacol 36: 149–154
Zohar J, Mueller EA, Insel TR, Zohar-Kadouch RC, Murphy DL (1987) Serotonergic responsivity in obsessive-compulsive disorder: comparison of patients and healthy controls. Arch Gen Psychiatry 44: 946–951
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hollander, E., Stein, D.J., Saoud, J.B. et al. Effects of fenfluramine on plasma homovanillic acid in healthy subjects. J. Neural Transmission 90, 81–84 (1992). https://doi.org/10.1007/BF01250520
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01250520